Description - Meyler's Side Effects of Endocrine and Metabolic Drugs by Jeffrey K. Aronson
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician and/or clinician. Diseases of the endocrine system are common, including diseases such as diabetes, thyroid disease, and obesity, as well as bone diseases like osteoporosis. Endocrinologists, internal medicine and primary care practitioners, bariatric physicians, diabetic professionals, and even OB/GYNs will find this volume useful when treating endocrine diseases with drug or hormonal therapy. * The only drug guide that includes clinical case studies and expert analysis * Most complete cross referencing of drug-drug interactions available * Features not only endocrine and metabolic drugs, but also all other drugs that act upon the endocrine system * Latest content from the most highly-regarded compilation of drug side effects: Side Effects of Drugs Annual serial
Buy Meyler's Side Effects of Endocrine and Metabolic Drugs by Jeffrey K. Aronson from Australia's Online Independent Bookstore, Boomerang Books.
(279mm x 210mm x mm)
Elsevier Science Ltd
Publisher: Elsevier Science & Technology
Country of Publication:
Book Reviews - Meyler's Side Effects of Endocrine and Metabolic Drugs by Jeffrey K. Aronson
Author Biography - Jeffrey K. Aronson
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is also the editor of Meyler's Side Effects of Drugs and the Side Effects of Drugs Annual series. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.